Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-31 @ 1:35 PM
Study NCT ID:
NCT07467993
Status:
RECRUITING
Last Update Posted:
2026-03-20
First Post:
2026-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-27
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-09
First Submit QC Date:
None
Study First Post Date:
2026-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-18
Last Update Post Date:
2026-03-20
Last Update Post Date Type:
ACTUAL